"Upstate Clinical Research Associates is a dedicated clinical research center conducting Phase II, III, and IV trials for the pharmaceutical industry giving all in our community access to the newest pharmaceutical therapies. We are known to our sponsors and CRO’s for having accelerated study start up, subject enrollment and excellent retention rates all while maintaining strict protocol adherence and the highest practice standards set by the industry. We are currently enrolling clinical research studies for: - Hot Flashes - Polycystic Ovarian Syndrome - Irritable Bowel Syndrome - Chronic Constipation - Celiac Disease (Gluten Intolerance) Give us a call today at 716-626-6320 to learn more!"

During the past decade, Upstate Clinical Research Associates conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 38 clinical trials were completed, i.e. on average, 131% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 23 clinical trials were completed. i.e. 209.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Upstate Clinical Research Associates" #1 sponsor was "Pfizer" with 10 trials, followed by "Allergan" with 3 trials sponsored, "BioDelivery Sciences International" with 3 trials sponsored, "Purdue Pharma LP" with 3 trials sponsored and "AEON Biopharma, Inc." with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Upstate Clinical Research Associates" #1 collaborator was "Medpace, Inc." with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator and "Covance" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Upstate Clinical Research Associates" are "Low Back Pain" (8 trials), "Migraine" (7 trials), "Chronic Pain" (6 trials), "Osteoarthritis, Knee" (6 trials) and "Fibromyalgia" (3 trials). Many other conditions were trialed in "Upstate Clinical Research Associates" in a lesser frequency.

Most popular intervention types in "Upstate Clinical Research Associates" are "Drug" (48 trials), "Biological" (3 trials), "Device" (3 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "ABP-450" (2 trials), "Buprenorphine" (2 trials), "Celecoxib" (2 trials) and "Dihydroergotamine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Upstate Clinical Research Associates" are 49 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Upstate Clinical Research Associates". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 42 completed trials in Upstate Clinical Research Associates, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Upstate Clinical Research Associates, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".